AnGes (TSE:4563) Cyclically Adjusted PS Ratio: (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4563 AnGes Inc TSE:4563
46 GF Score
Price 円39.00
GF Value 円50.49
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is AnGes Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


AnGes  (TSE:4563) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AnGes Cyclically Adjusted PS Ratio Related Terms


AnGes Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for AnGes's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnGes Cyclically Adjusted PS Ratio Chart

AnGes Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.71 17.97 13.13 13.77 18.45

AnGes Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.90 23.86 18.45 17.92 0.00

TSE:4563 vs VRTX, REGN, MRNA: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, AnGes's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AnGes Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnGes's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AnGes's Cyclically Adjusted PS Ratio falls into.


TSE:4563
46GF Score
AnGes Inc TSE:4563
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AnGes Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AnGes's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, AnGes's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/113.6000*113.6000
=0.000

Current CPI (Jun. 2026) = 113.6000.

AnGes Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.229 98.000 1.425
201612 3.650 98.400 4.214
201703 1.151 98.100 1.333
201706 1.093 98.500 1.261
201709 1.094 98.800 1.258
201712 1.378 99.400 1.575
201803 0.915 99.200 1.048
201806 1.202 99.200 1.376
201809 1.104 99.900 1.255
201812 3.406 99.700 3.881
201903 0.761 99.700 0.867
201906 0.907 99.800 1.032
201909 1.415 100.100 1.606
201912 0.026 100.500 0.029
202003 0.053 100.300 0.060
202006 0.090 99.900 0.102
202009 0.094 99.900 0.107
202012 0.087 99.300 0.100
202103 0.086 99.900 0.098
202106 0.075 99.500 0.086
202109 0.140 100.100 0.159
202112 0.128 100.100 0.145
202203 0.101 101.100 0.113
202206 0.108 101.800 0.121
202209 0.092 103.100 0.101
202212 0.118 104.100 0.129
202303 0.091 104.400 0.099
202306 0.185 105.200 0.200
202309 0.265 106.200 0.283
202312 0.254 106.800 0.270
202403 0.569 107.200 0.603
202406 0.986 108.200 1.035
202409 0.560 108.900 0.584
202412 0.731 110.700 0.750
202503 0.541 111.100 0.553
202506 0.748 111.700 0.761
202509 0.672 112.000 0.682
202512 0.643 113.000 0.646
202603 0.516 112.700 0.520
202606 0.000 113.600 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is AnGes (TSE:4563) Overvalued in 2026?

Based on GuruFocus' analysis, AnGes stock appears to be undervalued. The current stock price of 円39.00 is trading 22.8% below its estimated GF Value™ of 円50.49. GuruFocus considers AnGes to be Modestly Undervalued.

Key valuation signals for TSE:4563:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円50.49 vs. price of 円39.00 (22.8% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the TSE:4563 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AnGes Business Description

Other Exchanges AJW:Germany
Address 7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company is involved in research and development and sales of pharmaceuticals such as gene-based drugs (gene therapy products, nucleic acid drugs); contract testing for rare genetic diseases, etc.
46GF Score

Get the complete analysis for TSE:4563

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円39.00
Price
円50.49
GF Value